Quantcast

Latest MedImmune Stories

2011-05-13 09:00:00

GAITHERSBURG, Md., May 13, 2011 /PRNewswire/ -- MedImmune announced today it will present eight abstracts at the American Thoracic Society (ATS) International Conference in Denver, CO, May 13-18, 2011. "These data advance our understanding of thoracic diseases, highlighting our continued commitment to help improve patient health," said Bing Yao, Senior Vice President and Leader of the RIA innovative Medicines Unit (iMED) at MedImmune. MedImmune abstracts to be presented at the ATS...

2011-05-10 08:00:00

SAN DIEGO, May 10, 2011 /PRNewswire/ -- Pfenex Inc., an industry leader in protein expression through the Pfenex Expression Technology(TM) platform, announced today a three year strategic collaboration with MedImmune LLC, the global biologics business of AstraZeneca. The agreement provides MedImmune with non-exclusive access to Pfenex Expression Technology and scientific resources for the development of bioprocesses for human therapeutic proteins and vaccines. Pfenex Inc. will engineer...

2011-05-09 07:00:00

ROCKVILLE, Md., May 9, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results for the first quarter ended March 31, 2011. The company reported a net loss of $7.5 million, or $0.07 per share, for the first quarter of 2011, compared to a net loss of $10.3 million, or $0.10 per share, for the first quarter of 2010. The primary reason for the decreased loss during the quarter was due to lower research and development spending to support clinical trials of the...

2011-05-03 06:30:00

SOUTH SAN FRANCISCO, Calif., May 3, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2011. For the first quarter of 2011, Rigel reported a net loss of $20.8 million, or $0.40 per share, compared to a net loss of $22.3 million, or $0.43 per share, in the first quarter of 2010. Weighted average shares outstanding for the first quarter of 2011 and 2010 were 52.3 million and 52.0 million, respectively. There...

2011-05-01 08:00:00

GAITHERSBURG, Md., May 1, 2011 /PRNewswire/ -- MedImmune announced today it will present 11 abstracts at the Pediatric Academic Societies (PAS) Meeting at the Colorado Convention Center in Denver, CO, April 30 - May 3, 2011. These abstracts advance the body of existing data and knowledge surrounding influenza and respiratory syncytial virus (RSV) prevention, highlighting MedImmune's continued leadership in patient health. MedImmune abstracts to be presented at PAS regarding influenza...

2011-04-29 01:29:45

A study of H1N1 and seasonal influenza vaccination in a sample of black and Hispanic children in Atlanta found a low rate of vaccine acceptance among parents and caregivers. Only 36 percent of parents and caregivers indicated they would immunize children against H1N1, and 22 percent indicated their children received the seasonal influenza vaccine in the previous three months. The majority of children in the sample (71 percent) were from households with less than $40,000 in annual income....

2011-04-26 06:00:00

SUNNYVALE, Calif., April 26, 2011 /PRNewswire/ -- Cepheid (NASDAQ: CPHD) today announced it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® Flu. The diagnostic test, which runs on Cepheid's GeneXpert® System, simultaneously detects and differentiates Influenza A, Influenza B, and the 2009 H1N1 influenza virus in about one hour. (Photo: http://photos.prnewswire.com/prnh/20110426/LA89263) "With Xpert Flu,...

2011-04-19 15:10:00

ROCKVILLE, Md., April 19, 2011 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) announced today that Stanley C. Erck, its former Executive Chairman, has been appointed to the position of President and Chief Executive Officer and will remain as a member of the Board of Directors. In addition, current Board member James Young, Ph.D., will assume the position of Chairman of the Board. Mr. Erck has been an active member of Novavax's senior management team for the last year and has had extensive...

2011-03-30 16:00:00

QUEBEC CITY, QC, March 30 /PRNewswire-FirstCall/ -  Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the fourth quarter and year ended December 31, 2010. The Company's financial statements and management report are available at www.sedar.com and at www.medicago.com. Highlights...

2011-03-29 09:25:00

WASHINGTON, March 29, 2011 /PRNewswire/ -- MedImmune announced today it will present a total of 11 abstracts at the 45th National Immunization Conference (NIC) at the Washington Hilton in Washington, DC, March 28 - 31, 2011. These abstracts advance the body of existing data and knowledge surrounding influenza prevention and trends in vaccination, highlighting MedImmune's strong leadership in patient health in various medical settings. "MedImmune is pleased to announce new research on...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related